Literature DB >> 7747120

Hypoxia and the rheumatoid joint: immunological and therapeutic implications.

S E Edmonds1, G Ellis, K Gaffney, J Archer, D R Blake.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7747120     DOI： 10.3109/03009749509100921

Source DB:  PubMed          Journal:  Scand J Rheumatol Suppl        ISSN： 0301-3847


× No keyword cloud information.
  4 in total

Review 1.  Schiff base forming drugs: mechanisms of immune potentiation and therapeutic potential.

Authors:  H Chen; J Rhodes
Journal:  J Mol Med (Berl)       Date:  1996-09       Impact factor: 4.599

2.  The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis.

Authors:  Gert E Hein; Markus Köhler; Peter Oelzner; Günter Stein; Sybille Franke
Journal:  Rheumatol Int       Date:  2004-12-03       Impact factor: 2.631

3.  Suppression of human arthritis synovial fibroblasts inflammation using dexamethasone-carbon nanotubes via increasing caveolin-dependent endocytosis and recovering mitochondrial membrane potential.

Authors:  Yeon Kyung Lee; Sang-Woo Kim; Jun-Young Park; Woong Chol Kang; Youn Joo Kang; Dongwoo Khang
Journal:  Int J Nanomedicine       Date:  2017-08-10

4.  Chemical Hypoxia Brings to Light Altered Autocrine Sphingosine-1-Phosphate Signalling in Rheumatoid Arthritis Synovial Fibroblasts.

Authors:  Chenqi Zhao; Uriel Moreno-Nieves; John A Di Battista; Maria J Fernandes; Mohamed Touaibia; Sylvain G Bourgoin
Journal:  Mediators Inflamm       Date:  2015-10-18       Impact factor: 4.711
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.